Upregulation of UCP2 by adiponectin: The involvement of mitochondrial superoxide and hnRNP K

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Zhou, Mingyan ^a   Xu, Aimin ^a   Tam, Paul K H ^a   Lam, Karen S L ^a   Huang, Bosheng ^a   Liang, Yan ^a   Lee, In Kyu ^b   Wu, Donghai ^c   Wang, Yu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Kyungpook National University School of Medicine   (South Korea)

^c GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYCLOHEXIMIDE; DACTINOMYCIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; MESSENGER RNA; MITOCHONDRIAL SUPEROXIDE; ROTENONE; SUPEROXIDE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; CELL FRACTIONATION; CELL KINETICS; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETIC STABILITY; LIVER PARENCHYMA; MALE; MITOCHONDRIAL MEMBRANE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSIENT EXPRESSION; TRANSLATION REGULATION; UNCOUPLING PROTEIN 2 GENE; UPREGULATION; ANIMAL; BIOSYNTHESIS; CYTOLOGY; LIVER; LIVER MITOCHONDRION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ADIPONECTIN; ANIMALS; ENDOTHELIAL CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; ION CHANNELS; LIVER; MICE; MICE, KNOCKOUT; MITOCHONDRIA, LIVER; MITOCHONDRIAL PROTEINS; RNA, MESSENGER; SUPEROXIDES; UP-REGULATION;

EID: 84863121852     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032349     Document Type: Article

References (59)

1. Wree A, Kahraman A, Gerken G, Canbay A, (2011) Obesity affects the liver- the link between adipocytes and hepatocytes. Digestion 83: 124-133.
2. Balmer ML, Dufour JF, (2011) [Non-alcoholic steatohepatitis- from NAFLD to MAFLD]. Ther Umsch 68: 183-188.
3. Krawczyk M, Bonfrate L, Portincasa P, (2010) Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 24: 695-708.
4. Williams R, (2006) Global challenges in liver disease. Hepatology 44: 521-526.
5. Machado M, Cortez-Pinto H, (2006) Non-alcoholic steatohepatitis and metabolic syndrome. Curr Opin Clin Nutr Metab Care 9: 637-642.
6. McCullough AJ, (2004) The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8: 521-533 viii.
7. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, et al. (2002) NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36: 1349-1354.
8. Kadowaki T, Yamauchi T, Kubota N, (2008) The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett 582: 74-80.
9. Mangge H, Almer G, Truschnig-Wilders M, Schmidt A, Gasser R, et al. (2010) Inflammation, adiponectin, obesity and cardiovascular risk. Curr Med Chem 17: 4511-4520.
10. Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A, (2008) Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 114: 361-374.
11. Aygun C, Senturk O, Hulagu S, Uraz S, Celebi A, et al. (2006) Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease. Eur J Gastroenterol Hepatol 18: 175-180.
12. Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, et al. (2004) Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 89: 200-206.
13. Musso G, Gambino R, De Michieli F, Durazzo M, Pagano G, et al. (2008) Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. Hepatology 47: 1167-1177.
14. Polyzos SA, Kountouras J, Zavos C, Tsiaousi E, (2010) The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab 12: 365-383.
15. Vuppalanchi R, Marri S, Kolwankar D, Considine RV, Chalasani N, (2005) Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study. J Clin Gastroenterol 39: 237-242.
16. Wang Y, Zhou M, Lam KS, Xu A, (2009) Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. Arq Bras Endocrinol Metabol 53: 201-212.
17. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, et al. (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112: 91-100.
18. Yoneda M, Iwasaki T, Fujita K, Kirikoshi H, Inamori M, et al. (2007) Hypoadiponectinemia plays a crucial role in the development of nonalcoholic Fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue. Alcohol Clin Exp Res 31: S15-21.
19. Baranova A, Gowder SJ, Schlauch K, Elariny H, Collantes R, et al. (2006) Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance. Obes Surg 16: 1118-1125.
20. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, et al. (2004) Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40: 46-54.
21. Kamada Y, Matsumoto H, Tamura S, Fukushima J, Kiso S, et al. (2007) Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model. J Hepatol 47: 556-564.
22. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, et al. (2003) Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 125: 1796-1807.
23. Matsumoto H, Tamura S, Kamada Y, Kiso S, Fukushima J, et al. (2006) Adiponectin deficiency exacerbates lipopolysaccharide/D-galactosamine-induced liver injury in mice. World J Gastroenterol 12: 3352-3358.
24. Zhou M, Xu A, Tam PK, Lam KS, Chan L, et al. (2008) Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury. Hepatology 48: 1087-1096.
25. Ding X, Saxena NK, Lin S, Xu A, Srinivasan S, et al. (2005) The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol 166: 1655-1669.
26. Masaki T, Chiba S, Tatsukawa H, Yasuda T, Noguchi H, et al. (2004) Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology 40: 177-184.
27. Thakur V, Pritchard MT, McMullen MR, Nagy LE, (2006) Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding. Am J Physiol Gastrointest Liver Physiol 290: G998-1007.
28. Sennello JA, Fayad R, Morris AM, Eckel RH, Asilmaz E, et al. (2005) Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin. Endocrinology 146: 2157-2164.
29. Azzu V, Jastroch M, Divakaruni AS, Brand MD, (2010) The regulation and turnover of mitochondrial uncoupling proteins. Biochim Biophys Acta 1797: 785-791.
30. Baffy G, (2005) Uncoupling protein-2 and non-alcoholic fatty liver disease. Front Biosci 10: 2082-2096.
31. Zhou M, Xu A, Lam KS, Tam PK, Che CM, et al. (2010) Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin. J Hepatol 53: 1108-1116.
32. Ostrowski J, Klimek-Tomczak K, Wyrwicz LS, Mikula M, Schullery DS, et al. (2004) Heterogeneous nuclear ribonucleoprotein K enhances insulin-induced expression of mitochondrial UCP2 protein. J Biol Chem 279: 54599-54609.
33. Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, et al. (2000) Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26: 435-439.
34. Bai Y, Onuma H, Bai X, Medvedev AV, Misukonis M, et al. (2005) Persistent nuclear factor-kappa B activation in Ucp2-/- mice leads to enhanced nitric oxide and inflammatory cytokine production. J Biol Chem 280: 19062-19069.
35. Horimoto M, Fulop P, Derdak Z, Wands JR, Baffy G, (2004) Uncoupling protein-2 deficiency promotes oxidant stress and delays liver regeneration in mice. Hepatology 39: 386-392.
36. Sluse FE, Jarmuszkiewicz W, Navet R, Douette P, Mathy G, et al. (2006) Mitochondrial UCPs: new insights into regulation and impact. Biochim Biophys Acta 1757: 480-485.
37. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, et al. (1997) Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15: 269-272.
38. Negre-Salvayre A, Hirtz C, Carrera G, Cazenave R, Troly M, et al. (1997) A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J 11: 809-815.
39. Rousset S, Emre Y, Join-Lambert O, Hurtaud C, Ricquier D, et al. (2006) The uncoupling protein 2 modulates the cytokine balance in innate immunity. Cytokine 35: 135-142.
40. Fulop P, Derdak Z, Sheets A, Sabo E, Berthiaume EP, et al. (2006) Lack of UCP2 reduces Fas-mediated liver injury in ob/ob mice and reveals importance of cell-specific UCP2 expression. Hepatology 44: 592-601.
41. Cadenas E, Boveris A, Ragan CI, Stoppani AO, (1977) Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch Biochem Biophys 180: 248-257.
42. Hamanaka RB, Chandel NS, (2010) Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci 35: 505-513.
43. Rigoulet M, Yoboue ED, Devin A, (2010) Mitochondrial ROS generation and its regulation: mechanisms involved in H(2)O(2) signaling. Antioxid Redox Signal 14: 459-468.
44. Scherz-Shouval R, Elazar Z, (2011) Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci 36: 30-38.
45. Brand MD, Affourtit C, Esteves TC, Green K, Lambert AJ, et al. (2004) Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic Biol Med 37: 755-767.
46. Lambert AJ, Brand MD, (2004) Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I). J Biol Chem 279: 39414-39420.
47. Lambert AJ, Brand MD, (2004) Superoxide production by NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane. Biochem J 382: 511-517.
48. Dlaskova A, Hlavata L, Jezek J, Jezek P, (2008) Mitochondrial Complex I superoxide production is attenuated by uncoupling. Int J Biochem Cell Biol 40: 2098-2109.
49. Muller FL, Liu Y, Abdul-Ghani MA, Lustgarten MS, Bhattacharya A, et al. (2008) High rates of superoxide production in skeletal-muscle mitochondria respiring on both complex I- and complex II-linked substrates. Biochem J 409: 491-499.
50. Venables JP, Koh CS, Froehlich U, Lapointe E, Couture S, et al. (2008) Multiple and specific mRNA processing targets for the major human hnRNP proteins. Mol Cell Biol 28: 6033-6043.
51. Klimek-Tomczak K, Mikula M, Dzwonek A, Paziewska A, Wyrwicz LS, et al. (2006) Mitochondria-associated satellite I RNA binds to hnRNP K protein. Acta Biochim Pol 53: 169-178.
52. Ostrowski J, Wyrwicz L, Rychlewski L, Bomsztyk K, (2002) Heterogeneous nuclear ribonucleoprotein K protein associates with multiple mitochondrial transcripts within the organelle. J Biol Chem 277: 6303-6310.
53. Schullery DS, Ostrowski J, Denisenko ON, Stempka L, Shnyreva M, et al. (1999) Regulated interaction of protein kinase Cdelta with the heterogeneous nuclear ribonucleoprotein K protein. J Biol Chem 274: 15101-15109.
54. Bogoyevitch MA, Kobe B, (2006) Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol Mol Biol Rev 70: 1061-1095.
55. Ostareck-Lederer A, Ostareck DH, Cans C, Neubauer G, Bomsztyk K, et al. (2002) c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs. Mol Cell Biol 22: 4535-4543.
56. Habelhah H, Shah K, Huang L, Ostareck-Lederer A, Burlingame AL, et al. (2001) ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat Cell Biol 3: 325-330.
57. Wang Y, Lam KS, Xu JY, Lu G, Xu LY, et al. (2005) Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280: 18341-18347.
58. Wang Y, Xu A, Knight C, Xu LY, Cooper GJ, (2002) Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J Biol Chem 277: 19521-19529.
59. Mukhopadhyay P, Rajesh M, Hasko G, Hawkins BJ, Madesh M, et al. (2007) Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy. Nat Protoc 2: 2295-2301.